Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00099437 · BASELINE

Baseline characteristics

Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy. · Source last updated 2026-06-11

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      374
    2. group Id
      BG001
      value
      362
    3. group Id
      BG002
      value
      736
    units
    Participants
groups
  1. description
    Fulvestrant 250 mg Intramuscular Injection every 28 days
    id
    BG000
    title
    Fulvestrant 250 mg
  2. description
    Fulvestrant 500 mg Intramuscular Injection every 28 days plus 500 mg on day 14
    id
    BG001
    title
    Fulvestrant 500 mg
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          11.94
          value
          60.8
        2. group Id
          BG001
          spread
          11.47
          value
          61.0
        3. group Id
          BG002
          spread
          11.71
          value
          60.9
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    Years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          374
        2. group Id
          BG001
          value
          362
        3. group Id
          BG002
          value
          736
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          0
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      374
    2. group Id
      BG001
      value
      362
    3. group Id
      BG002
      value
      736
    units
    Participants
groups
  1. description
    Fulvestrant 250 mg Intramuscular Injection every 28 days
    id
    BG000
    title
    Fulvestrant 250 mg
  2. description
    Fulvestrant 500 mg Intramuscular Injection every 28 days plus 500 mg on day 14
    id
    BG001
    title
    Fulvestrant 500 mg
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          11.94
          value
          60.8
        2. group Id
          BG001
          spread
          11.47
          value
          61.0
        3. group Id
          BG002
          spread
          11.71
          value
          60.9
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    Years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          374
        2. group Id
          BG001
          value
          362
        3. group Id
          BG002
          value
          736
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          0
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice